Laboratoris Sanifit, a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, has announced the appointment of Keith Leonard to the Board of Directors.
Keith was co-founder, President and Chief Executive Officer of Kythera Biopharmaceuticals from 2005 until its acquisition by Allergan in October 2015 for $2.1 billionn. Prior to that he held various positions at Amgen, including the creation of Amgen’s Rheumatology Business Unit, and as Senior Vice President and General Manager of Amgen Europe, responsible for commercial operations in 28 European countries.
Commenting on the appointment, Joan Perelló, CEO of Sanifit said, “Keith possesses deep experience within the industry, and his background and proven track record make him a valuable addition to our Board. During his time at Kythera, he transformed the company, and managed its acquisition by Allergan. We are delighted to benefit from his unique insights, and his experience in building successful companies will prove invaluable as we drive Sanifit forward to reach its full potential.”
